Pharmacokinetic analysis of two different docetaxel dose levels in patients with non-small cell lung cancer treated with docetaxel as monotherapy or with concurrent radiotherapy

Pharmacokinetic analysis of two different docetaxel dose levels in patients with non-small cell lung cancer treated with docetaxel as monotherapy or with concurrent radiotherapy

<p>Abstract</p> <p>Background</p> <p>Previous pharmacokinetic studies with docetaxel have mostly used 3-weekly (75 mg/m<sup>2 </sup>and 100 mg/m<sup>2</sup>) or weekly regimens (35–40 mg/m<sup>2</sup>). The pharmacokinetics and radios...

Full description

Bibliographic Details
Main Authors: Kristensen Vessela, Aamdal Steinar, Andersen Anders, Fr Brunsvig Paal, Olsen Harald
Format: Article
Language:English
Published: BMC 2007-10-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/7/197

Similar Items

Similar Items